| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ULTRASMEDBIO.2018.01.001 |
| P698 | PubMed publication ID | 29548756 |
| P50 | author | Jonathan R Lindner | Q89706631 |
| P2093 | author name string | Craig C Weinkauf | |
| Evan Unger | |||
| Brian P Davidson | |||
| J Todd Belcik | |||
| Federico Moccetti | |||
| Edmund R Marinelli | |||
| P2860 | cites work | Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis | Q27339951 |
| Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice | Q28267720 | ||
| Myocardial ischemic memory imaging with molecular echocardiography | Q30432468 | ||
| Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow | Q30433437 | ||
| Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance | Q30434516 | ||
| Vascular adhesion molecules in atherosclerosis | Q30444182 | ||
| Noninvasive ultrasound molecular imaging of the effect of statins on endothelial inflammatory phenotype in early atherosclerosis | Q30455730 | ||
| Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype | Q30473382 | ||
| Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease | Q30492960 | ||
| Detection of antecedent myocardial ischemia with multiselectin molecular imaging | Q30559110 | ||
| P-selectin as a candidate target in atherosclerosis | Q30979264 | ||
| LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. | Q34079451 | ||
| Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial | Q34120778 | ||
| Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis | Q35936550 | ||
| Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk | Q36475652 | ||
| Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. | Q36617730 | ||
| In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences | Q37457295 | ||
| Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography | Q37511734 | ||
| Proinflammatory endothelial activation detected by molecular imaging in obese nonhuman primates coincides with onset of insulin resistance and progressively increases with duration of insulin resistance | Q37540095 | ||
| Anti-inflammatory therapeutics for the treatment of atherosclerosis | Q37626768 | ||
| Landmark lipid-lowering trials in the primary prevention of cardiovascular disease. | Q38110701 | ||
| Anti-inflammatory therapies for atherosclerosis | Q38349757 | ||
| Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events | Q39309074 | ||
| Identification of peptides that target the endothelial cell-specific LOX-1 receptor. | Q40822981 | ||
| Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia | Q44010401 | ||
| The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. | Q45992172 | ||
| A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. | Q46778536 | ||
| Intravascular ultrasound molecular imaging of atheroma components in vivo | Q47972229 | ||
| Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study | Q48952305 | ||
| Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. | Q50970470 | ||
| A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis. | Q54691400 | ||
| Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis | Q56894441 | ||
| Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium | Q78567192 | ||
| Contrast echocardiography | Q79510358 | ||
| Molecular imaging of vascular phenotype in cardiovascular disease: new diagnostic opportunities on the horizon | Q83983757 | ||
| P433 | issue | 6 | |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 1155-1163 | |
| P577 | publication date | 2018-03-13 | |
| P1433 | published in | Ultrasound in Medicine and Biology | Q2260380 |
| P1476 | title | Ultrasound Molecular Imaging of Atherosclerosis Using Small-Peptide Targeting Ligands Against Endothelial Markers of Inflammation and Oxidative Stress | |
| P478 | volume | 44 |
| Q93017847 | Applications of Ultrasound to Stimulate Therapeutic Revascularization |
| Q91943358 | In vivo assessment of inflammation in carotid atherosclerosis by noninvasive photoacoustic imaging |
| Q92396778 | Seeing the Invisible-Ultrasound Molecular Imaging |
| Q64230672 | Single-Chain Variable Fragment Antibody of Vascular Cell Adhesion Molecule 1 as a Molecular Imaging Probe for Colitis Model Rabbit Investigation |
Search more.